ISR's CRO Quality Benchmarking - Phase IV Service Providers (9th Edition) report provides pharmaceutical sponsors and service providers a Consumer Reports-style analysis of CRO quality. Respondents supplied performance ratings based on their experiences with 24 Phase IV CROs, making this report the most comprehensive assessment of CRO service quality in the industry. Now in its 9th year, this report has become a crucial tool for sponsors looking to select a Phase IV CRO and for service providers seeking an experience-based evaluation of their strengths and weaknesses.
Make a more informed purchase of Phase IV services by understanding which service providers best fit your company's needs
Broaden your Phase IV CRO evaluation list by accessing peer-based service quality ratings across 26 critical attributes
Pinpoint potential delivery concerns early in a sponsor
CRO relationship in order to develop proactive strategies to address potential gaps
Clinical Service Providers
Uncover your own-and competitor-delivery strengths and weaknesses
Design messaging to tout your company’s strengths
Compete more effectively by understanding buyers’ selection criteria and outsourcing trends
